Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | GMNN | O75496 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2858662 | 1.00 | TP53 (0.47) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL11607011 | 1.00 | TP53 (0.47) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL31562869 | 1.00 | TP53 (0.47) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL3427003 | 0.98 | TP53 (0.43) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL4535941 | 0.98 | TP53 (0.48) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL1663576 | 0.96 | TP53 (0.45) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL9558017 | 0.94 | GPR84 (0.41) | — | |
| SCHEMBL3155145 | 0.92 | TP53 (0.50) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL17099449 | 0.90 | GPR84 (0.43) | LMNA | |
| SCHEMBL3490657 | 0.90 | GPR84 (0.43) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1055697-C | Phospholipi derivatives containing higher elements of the Vth main group | ASTA MEDICA AG (DE) | 2000-08-23 | — | — | CN | disclosed |
| US-5958906-A | Phospholipid derivatives containing higher elements of the fifth main group | ASTA-MEDICA AKTIENGESELLSCHAFT (DE) | 1999-09-28 | — | — | US | disclosed |
| US-5637577-A | TREATMENT OF POTOZOAL DISEASES | ASTA MEDICA AKTIENGESELLSCHAFT (DE) | 1997-06-10 | — | — | US | disclosed |
| US-5449798-A | Phospholipid derivatives containing higher elements of the fifth group | ASTA MEDICA AKTIENGESELLSCHAFT (DE) | 1995-09-12 | — | — | US | disclosed |
| CN-1088583-A | The phospholipid derivative that contains the 5th main group higher elements | ASTA MEDICA AG (DE) | 1994-06-29 | — | — | CN | disclosed |
| EP-0594999-A1 | Phospholipid derivatives containing higher elements of the fifth main group | ASTA Medica Aktiengesellschaft (DE) | 1994-05-04 | — | — | EP | disclosed |